Her doctor was concerned, but mentioned that the bleeding could be due to an internal hemorrhoid, which is common after childbirth. But results from an at-home stool test indicated Qadir needed a ...

Carnegie Mellon University’s Summer Undergraduate Research Fellowship (SURF) program provides funding for undergraduates to work full time on research projects during the summer. Many students ...

A Dutch crop technology company has developed a breakthrough method to create stable graft chimeras—plants that combine the ...

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes ...

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing ...

From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Treyson Wallace was diagnosed with Argonaut syndrome at the Undiagnosed Disease Program at UW-Madison's Center for Human Genomics and Precision Medicine.

South Korea-based multinational electronics giant Samsung wanted to invest $22 billion in Bangladesh during the Awami League regime but backtracked from their decision due to land-related problems, ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

The I148M mutation in the PNPLA3 gene, which encodes patatin-like phospholipase domain-containing protein 3, is known to confer risk of fatty liver, cirrhosis and hepatic inflammation, which may lead ...

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price reduced by Needham & Company LLC from $202.00 to $183.00 in a report published on Thursday,Benzinga reports. Needham & Company LLC ...

A revolution is underway in gene editing -- and at its forefront is David Liu, an American molecular biologist whose ...